# A Observational Study to Evaluate the Efficacy and Safety of Pacitol Inj.

> **NCT06126016** · — · RECRUITING · sponsor: **Boryung Pharmaceutical Co., Ltd** · enrollment: 1000 (estimated)

## Conditions studied

- Chronic Kidney Disease 5D
- Secondary Hyperparathyroidism

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06126016
- **Lead sponsor:** Boryung Pharmaceutical Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-19
- **Primary completion:** 2026-04
- **Final completion:** 2026-04
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2024-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06126016

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06126016, "A Observational Study to Evaluate the Efficacy and Safety of Pacitol Inj.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06126016. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*